# AngioGenix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/angiogenix

- Industry: Biotechnology
- Headquarters: Burlingame, US
- Total disclosed funding: $4.1M
- Latest round: Series D (Jan 13, 2005)
- Investors on record: 4

## About

Based in California, US, AngioGenex, Inc. operates as a biotechnology company that develops treatments for peripheral and cardiac ischemia.

## Funding rounds

- Series D, Jan 13, 2005, $4.1M — RBC Capital Markets, Teknoinvest Management, Latham & Watkins, AIG Global Investment Group

## Investors

- RBC Capital Markets (https://capitalatlas.ai/funds/rbc-capital-markets) — Series D
- Teknoinvest Management (https://capitalatlas.ai/funds/teknoinvest-management) — Series D
- Latham & Watkins — Series D
- AIG Global Investment Group — Series D